Analyst Expectations for RxSight's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 Wall Street analysts have provided ratings on RxSight (NASDAQ:RXST), with 2 giving a bullish and 2 a somewhat bullish outlook. The average price target among them is $37.0, which is below the current price of $38.5, suggesting a downside. The average price target has increased by 2.78% over the past month. Analysts typically review stocks quarterly or after major company updates, using financial predictions and company performance to guide their ratings.
December 13, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have a positive outlook on RxSight with an average price target of $37.0, which is below the current price, indicating a potential downside. The price target has seen a slight increase over the past month.
The consensus among analysts suggests a somewhat bullish sentiment, but the average price target is below the current stock price, which could lead to a short-term negative impact on the stock price. The importance is high as analyst ratings can influence market perceptions, but not at the maximum because other factors also affect stock prices. The confidence level is not at the maximum due to the inherent uncertainty in predicting stock movements based on analyst ratings.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100